Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A
1(50.0%)
Phase 1
1(50.0%)
2Total
N/A(1)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT06069791Phase 1Recruiting

Greater Occipital Nerve Blockade in Veterans With Post-concussion Headache: Sub-study 1

Role: collaborator

NCT01257893Not ApplicableWithdrawn

Aspirin Resistance in Women With Migraine

Role: collaborator

NCT01257880Completed

Comorbidities Associated With Migraine and Patent Foramen Ovale (CAMP)

Role: collaborator

All 3 trials loaded